Enzalutamide (Xtandi) in combination with leuprolide acetate produced a significant benefit in terms of overall survival (OS) vs leuprolide acetate alone for the treatment of patients with high-risk, biochemically recurrent prostate cancer,…
Category: 6. Health
-

This powerful drug combo cuts prostate cancer deaths by 40%
Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of death by more than 40%.
Researchers tested a therapy that combines…
Continue Reading
-

Afghanistan confirms new polio case in Uruzgan, raising 2025 total to 9 amid security challenges
Kabul [Afghanistan], October 19 (ANI): Afghanistan confirmed a new polio case in Uruzgan province, raising the country’s total for 2025 to nine, Tolo News reported. Officials warned that continued insecurity hampers nationwide vaccination…
Continue Reading
-

Cancer patients who got a COVID vaccine lived much longer
People with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of beginning immunotherapy lived considerably longer than those who did not, according to new research.
Scientists from the University of Florida and…
Continue Reading
-

5 best fruits for liver health: Doctor-approved detox foods to flush out toxins and boost your health
Your liver quietly works 24/7, filtering toxins, balancing hormones, and keeping digestion smooth. But in a world of junk food, alcohol, and late-night eating, this hardworking organ often takes the hit first. The good news? You can help your…Continue Reading
-

Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer
The addition of atezolizumab (Tecentriq) to chemotherapy demonstrated noninferior survival compared with placebo plus chemotherapy in patients with advanced or recurrent endometrial cancer, according to a presentation on the phase 3…
Continue Reading
-

Enzalutamide/Leuprolide Leads to 40% Lower Risk of Death in Prostate Cancer | Targeted Oncology
The addition of enzalutamide (Xtandi) to leuprolide acetate resulted in a 40.3% lower risk of death compared with leuprolide acetate alone in patients with high-risk, biochemically recurrent prostate cancer, according to the final overall…
Continue Reading
-

Liver cancer now strikes the healthy too: Here’s what doctors say people should watch for
Do you sometimes feel constantly tired, no matter how much rest you get? Or experience a lingering, mild pain on the upper right side of your abdomen? You may even notice a faint yellow tinge in your skin or eyes – signs we often brush off as…
Continue Reading
-

What to Know About Interactions Between Collagen Supplements and Medications
- Collagen is naturally found in our body and often taken as a supplement to support aging and injury prevention.
- Collagen supplements may have added ingredients such as vitamins or herbs that can interact with some medications.
- Choose collagen…
Continue Reading
-

WHO: One in Five African Infections Now Resistant to Antibiotics
- Over 70% of key bacteria resist standard treatments in Africa
- WHO urges urgent action to prevent global health crisis
Antibiotic resistance now affects one in five infections across Africa, surpassing the global average, where one in…
Continue Reading
